Table 3.

Predicted survival functions for the panitumumab data

Time (Days)	ITT		No Crossover		IPE		Shao Cox		TM
	BSC	P+BSC	BSC	P+BSC	BSC	P+BSC	BSC	P+BSC	BSC	P+BSC
93	0.750	0.793	0.303	0.793	0.722	0.783	0.678	0.798	0.548	0.801
190	0.511	0.533	0.081	0.533	0.454	0.551	0.341	0.536	0.171	0.555
334	0.266	0.260	0.020	0.260	0.201	0.298	0.097	0.258	0.025	0.282
1024	0.013	0.038	0.020	0.038	0.001	0.007	0.001	0.023	0.001	0.026
p-value	0.577		<0.001		0.520		0.002		<0.001

ITT, intent-to-treat; IPE, Branson & Whitehead (2002); Shao Cox, Shao et al. (2005); TM, proposed method; BSC, best supportive care alone; P+BSC, panitumumab plus best supportive care.